Target audience: 
  • Physicians
  • Physician Assistants
  • Nurse Practitioners
Learning objectives: 

Participants who engage in this educational intervention will be able to:

  1. Identify and discuss lupus nephritis.
  2. Discuss standard medical therapy of lupus nephritis.
  3. Evaluate the efficacy and outcomes of AURORA 1 trial.
Faculty & credentials: 

Speaker(s):

Saqib Mahmud, MD
Nephrology Fellow
Department of Medicine
Medical College of Wisconsin

 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

  •  Saqib Mahmud, MD

 

In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
 

NameCompanyRole

 

Contact

Name: 
Carriann Horstead
Phone number: 
+1 (414) 955-0300

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 

Session date: 
Tuesday, May 25, 2021 - 3:30pm to 4:30pm
Location: 
Virtual Meeting & HUB A7520/7628
WI
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.